# Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy

> **NCT05465512** · — · COMPLETED · sponsor: **Fujian Medical University** · enrollment: 193 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **OTHER:** response to neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT05465512
- **Lead sponsor:** Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-04
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-07-10
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05465512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05465512, "Using Radiomics to Predict Neoadjuvant Chemotherapy Efficacy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05465512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*